Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease
Clinical trial NCT01051115 · UNKNOWN
Trial details
- NCT number
- NCT01051115
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2013-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.